News

The partnership with Flagship will bring Novo Nordisk into closer contact with the VC's portfolio of 41 biotech companies, with the aim of creating a portfolio of "transformational" medicines for ...
Novo Nordisk has reported new data with its long-acting human growth hormone (hGH) product Sogroya, showing it is at least as effective as its older drug Norditropin in various paediatric growth ...
Novo Nordisk was the company of 2023, soaring to the mantle of Europe’s most valuable company as its bumper weight ...
The fact the NHS is going to prioritise Mounjaro, might force Novo Nordisk [the Danish manufacturer of Wegovy] to lower prices,' says Prof Sattar. Q. I have heard that patients who come off the ...